Checkpoints Under Traffic Control: From and to Organelles

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Immune checkpoints regulate immune homeostasis through stimulatory and inhibitory signals.
• Key checkpoint molecules include PD1, PD-L1, and CTLA-4, which are transmembrane proteins.
• While checkpoint molecules are well-studied, their trafficking remains under-explored.

Purpose of the Study:

• To review the trafficking mechanisms of immune checkpoint molecules.
• To highlight the role of trafficking in immune regulation and disease.
• To identify potential drug targets based on checkpoint trafficking pathways.

Main Methods:

• Literature review focusing on immune checkpoint trafficking.
• Analysis of key regulators of PD-L1 trafficking.
• Examination of checkpoint molecules like PD-L1, CTLA-4, LAG-3, KIRs, CD70, and CD94.

Main Results:

• Immune checkpoint molecules, particularly PD-L1, are transmembrane proteins with shared trafficking characteristics.
• Regulators of PD-L1 trafficking include metformin, CMTM, HIP1R, exosomes, ALIX, and post-translational modifications.
• Checkpoint trafficking is implicated in various pathophysiological conditions.

Conclusions:

• Understanding immune checkpoint trafficking is essential for advancing immunotherapy.
• Checkpoint trafficking pathways offer potential targets for novel drug development.
• Further research into combinatorial therapeutic strategies targeting these pathways is warranted.